Doxecitine and Doxribtimine-Expanded Access
NCT06590493
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Thymine Kinase 2 Deficiency
Interventions
DRUG:
doxecitine and doxribtimine
Sponsor
UCB BIOSCIENCES, Inc.